Keyphrases
Complete Tumor Regression
100%
Vaccination
100%
Adenoviral
100%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
100%
Combinational Therapy
100%
Blockage
100%
Tumor-specific
66%
T Cell Depletion
33%
Adenovirus
33%
Therapeutic Vaccination
33%
CD8+ T Cells
33%
Vaccine Candidate
33%
Tumor Growth
33%
Invariant Chain
33%
Spleen
33%
Viral Antigens
33%
Booster Vaccination
33%
CTLA-4 Inhibitors
33%
Agonistic
33%
Monoclonal Antibody
33%
Replication-deficient
33%
Clinically Significant
33%
Specific Response
33%
Therapeutic Vaccine
33%
CD8+ T Cell Response
33%
Effect Analysis
33%
Melanoma
33%
Tumor Control
33%
Clinical Effect
33%
Tumor
33%
Long-term Survival
33%
Immunology and Microbiology
CTLA-4
100%
Monoclonal Antibody
100%
Cytotoxic T-Cell
100%
Long Term Survival
50%
Tumor Vaccine
50%
Adenoviridae
50%
Invariant Chain
50%
Virus Antigen
50%
T Cell Depletion
50%